HuGE Literature Finder
Records
1
-
30
| Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer. Journal of ovarian research 2021 Oct 14 (1): 129. Watanabe Takafumi, Nanamiya Hideaki, Endo Yuta, Kojima Manabu, Nomura Shinji, Furukawa Shigenori, Soeda Shu, Tamura Hirosumi, Ryufuku Masae, Tanaka Daisuke, Isogai Takao, Imai Jun-Ichi, Watanabe Shinya, Fujimori Kei |
| A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients. Scientific reports 2021 Jan 11 (1): 387. Zhang Yingli, Shi Xiaoliang, Zhang Jiejie, Chen Xi, Zhang Peng, Liu Angen, Zhu T |
| Whole Exome Sequencing in BRCA1-2 Candidate Families: The Contribution of Other Cancer Susceptibility Genes. Frontiers in oncology 2021 11 649435. Doddato Gabriella, Valentino Floriana, Giliberti Annarita, Papa Filomena Tiziana, Tita Rossella, Bruno Lucia Pia, Resciniti Sara, Fallerini Chiara, Benetti Elisa, Palmieri Maria, Mencarelli Maria Antonietta, Fabbiani Alessandra, Bruttini Mirella, Orrico Alfredo, Baldassarri Margherita, Fava Francesca, Lopergolo Diego, Lo Rizzo Caterina, Lamacchia Vittoria, Mannucci Sara, Pinto Anna Maria, Curr Aurora, Mancini Virginia, , , Mari Francesca, Renieri Alessandra, Ariani Frances |
| DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome. Cancers 2020 Jun 12 (7): . Tomasova Kristyna, Cumova Andrea, Seborova Karolina, Horak Josef, Koucka Kamila, Vodickova Ludmila, Vaclavikova Radka, Vodicka Pav |
| Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging 2020 Feb 12 . Chen Bo, Zhang Guochun, Li Xuerui, Ren Chongyang, Wang Yulei, Li Kai, Mok Hsiaopei, Cao Li, Wen Lingzhu, Jia Minghan, Li Cheukfai, Guo Liping, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Han-Zhang Han, Liu Jing, Lizaso Analyn, Liao Ni |
| Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC medical genomics 2020 Feb 13 (1): 21. da Costa E Silva Carvalho Simone, Cury Nathalia Moreno, Brotto Danielle Barbosa, de Araujo Luiza Ferreira, Rosa Reginaldo Cruz Alves, Texeira Lorena Alves, Plaça Jessica Rodrigues, Marques Adriana Aparecida, Peronni Kamila Chagas, Ruy Patricia de Cássia, Molfetta Greice Andreotti, Moriguti Julio Cesar, Carraro Dirce Maria, Palmero Edenir Inêz, Ashton-Prolla Patricia, de Faria Ferraz Victor Evangelista, Silva Wilson Arau |
| Therapeutic options for mucinous ovarian carcinoma. Gynecologic oncology 2020 Jan . Gorringe Kylie L, Cheasley Dane, Wakefield Matthew J, Ryland Georgina L, Allan Prue E, Alsop Kathryn, Amarasinghe Kaushalya C, Ananda Sumitra, Bowtell David D L, Christie Michael, Chiew Yoke-Eng, Churchman Michael, DeFazio Anna, Fereday Sian, Gilks C Blake, Gourley Charlie, Hadley Alison M, Hendley Joy, Hunter Sally M, Kaufmann Scott H, Kennedy Catherine J, Köbel Martin, Le Page Cecile, Li Jason, Lupat Richard, McNally Orla M, McAlpine Jessica N, Pyman Jan, Rowley Simone M, Salazar Carolina, Saunders Hugo, Semple Timothy, Stephens Andrew N, Thio Niko, Torres Michelle C, Traficante Nadia, Zethoven Magnus, Antill Yoland C, Campbell Ian G, Scott Clare |
| Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients. Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
| Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study. Journal of ovarian research 2019 Aug 12 (1): 80. Li Wenhui, Shao Di, Li Lei, Wu Ming, Ma Shuiqing, Tan Xianjie, Zhong Sen, Guo Fengming, Wang Zhe, Ye Mingz |
| Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
| Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube. Journal of gynecologic oncology 2018 Mar . Choi Min Chul, Bae Jin Sik, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Kim Ji Ho, Lee Ki Chan, Lee Sunghoon, Lee Je |
| Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication. Clinical genetics 2018 03 93 (3): 595-602. Pelttari L M, Shimelis H, Toiminen H, Kvist A, Törngren T, Borg Å, Blomqvist C, Bützow R, Couch F, Aittomäki K, Nevanlinna |
| High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
| Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population. Clujul medical (1957) 2018 91 (2): 157-165. Goidescu Iulian Gabriel, Caracostea Gabriela, Eniu Dan Tudor, Stamatian Florin Vasi |
| Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer. JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
| Mutational heterogeneity in non-serous ovarian cancers. Scientific reports 2017 Aug 7 (1): 9728. Teer Jamie K, Yoder Sean, Gjyshi Anxhela, Nicosia Santo V, Zhang Chaomei, Monteiro Alvaro N |
| Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53. International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
| Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Sep . Geurts-Giele Willemina R R, van Verschuer Victorien M T, van Deurzen Carolien H M, van Diest Paul J, Pedrosa Rute M S M, Collée J Margriet, Koppert Linetta B, Seynaeve Caroline, Dinjens Winand N |
| A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
| Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Mar . Tung Nadine, Lin Nancy U, Kidd John, Allen Brian A, Singh Nanda, Wenstrup Richard J, Hartman Anne-Renee, Winer Eric P, Garber Judy |
| Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations. Human mutation 2016 Feb . Caminsky Natasha G, Mucaki Eliseos J, Perri Ami M, Lu Ruipeng, Knoll Joan H M, Rogan Peter |
| Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast cancer research and treatment 2015 Dec . Ngeow Joanne, Sesock Kaitlin, Eng Char |
| Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis. Revista da Associac?a?o Me?dica Brasileira (1992) 2015 Oct 61 (5): 474-83. Encinas Giselly, Maistro Simone, Pasini Fátima Solange, Katayama Maria Lucia Hirata, Brentani Maria Mitzi, Bock Geertruida Hendrika de, Folgueira Maria Aparecida Azevedo Koi |
| Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing. International journal of oncology 2015 Jun 46 (6): 2389-98. Takenaka Masataka, Saito Motonobu, Iwakawa Reika, Yanaihara Nozomu, Saito Misato, Kato Mamoru, Ichikawa Hitoshi, Shibata Tatsuhiro, Yokota Jun, Okamoto Aikou, Kohno Takas |
| Inherited predisposition to breast cancer among African American women. Breast cancer research and treatment 2015 Jan 149 (1): 31-9. Churpek Jane E, Walsh Tom, Zheng Yonglan, Moton Zakiya, Thornton Anne M, Lee Ming K, Casadei Silvia, Watts Amanda, Neistadt Barbara, Churpek Matthew M, Huo Dezheng, Zvosec Cecilia, Liu Fang, Niu Qun, Marquez Rafael, Zhang Jing, Fackenthal James, King Mary-Claire, Olopade Olufunmilayo |
| Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms. BMC cancer 2015 15 (1): 415. Mackenzie Robertson, Kommoss Stefan, Winterhoff Boris J, Kipp Benjamin R, Garcia Joaquin J, Voss Jesse, Halling Kevin, Karnezis Anthony, Senz Janine, Yang Winnie, Prigge Elena-Sophie, Reuschenbach Miriam, Doeberitz Magnus Von Knebel, Gilks Blake C, Huntsman David G, Bakkum-Gamez Jamie, McAlpine Jessica N, Anglesio Michael |
| Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
| Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients. BMC medical genetics 2014 15 (1): 55. Silva Felipe C, Lisboa Bianca Cg, Figueiredo Marcia Cp, Torrezan Giovana T, Santos Erika Mm, Krepischi Ana C, Rossi Benedito M, Achatz Maria I, Carraro Dirce |
| The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. The Lancet. Oncology 2013 Aug 14 (9): 882-92. Sandhu Shahneen K, Schelman William R, Wilding George, Moreno Victor, Baird Richard D, Miranda Susana, Hylands Lucy, Riisnaes Ruth, Forster Martin, Omlin Aurelius, Kreischer Nathan, Thway Khin, Gevensleben Heidrun, Sun Linda, Loughney John, Chatterjee Manash, Toniatti Carlo, Carpenter Christopher L, Iannone Robert, Kaye Stan B, de Bono Johann S, Wenham Robert |
| PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? The oncologist 2013 18 (10): 1083-90. Mester Jessica L, Moore Rebekah A, Eng Char |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: